The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oosterhuis, H. (1997) · Cited by 2,397
Myasthenia gravis: Recommendations for clinical research standards
Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America, Jaretzki, A., Barohn, R. J., Ernstoff, R. M., Kaminski, H. J., Keesey, J. C., Penn, A. S., & Sanders, D. B. (2000) · Neurology · doi:10.1212/wnl.55.1.16 · Cited by 1,651
Hoch, W., McConville, J., Helms, S., Newsom-Davis, J., Melms, A., & Vincent, A. (2001) · Nature Medicine · doi:10.1038/85520 · Cited by 1,183
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
Meriggioli, M. N., & Sanders, D. B. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70063-8 · Cited by 894
Autoantibodies to low‐density lipoprotein receptor–related protein 4 in myasthenia gravis
Higuchi, O., Hamuro, J., Motomura, M., & Yamanashi, Y. (2011) · Annals of Neurology · doi:10.1002/ana.22312 · Cited by 535
IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†
Leite, M. I., Jacob, S., Viegas, S., Cossins, J., Clover, L., Morgan, B. P., Beeson, D., Willcox, N., & Vincent, A. (2008) · Brain · doi:10.1093/brain/awn092 · Cited by 527
LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction
Weatherbee, S. D., Anderson, K. V., & Niswander, L. A. (2006) · Development · doi:10.1242/dev.02696 · Cited by 351
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
Marx, A., Pfister, F., Schalke, B., Saruhan-Direskeneli, G., Melms, A., & Ströbel, P. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.03.007 · Cited by 351
Self-citationAnti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis
Pevzner, A., Schoser, B., Peters, K., Cosma, N.-C., Karakatsani, A., Schalke, B., Melms, A., & Kröger, S. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6194-7 · Cited by 342
Tzartos, J. S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2393 · Cited by 342
Self-citationMarques, M. J., Conchello, J.-A., & Lichtman, J. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03663.2000 · Cited by 193
Response to Therapy in Myasthenia Gravis with Anti‐MuSK Antibodies
Evoli, A., Bianchi, M. R., Riso, R., Minicuci, G. M., Batocchi, A. P., Servidei, S., Scuderi, F., & Bartoccioni, E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1405.012 · Cited by 158
Self-citationThe search for new antigenic targets in myasthenia gravis
Cossins, J., Belaya, K., Zoltowska, K. M., Koneczny, I., Maxwell, S., Jacobson, L. W., Leite, M. I., Waters, P. J., Vincent, A. C., & Beeson, D. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06833.x · Cited by 106
Epidemiology of seropositive myasthenia gravis in Greece
Poulas, K. A. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.3.352 · Cited by 106
Myasthenia Gravis Seronegative for Acetylcholine Receptor Antibodies
Vincent, A. C., Leite, M. I., Farrugia, M. E., Jacob, S., Viegas, S., Shiraishi, H., Benvéniste, O., Morgan, B. P., Hilton‐Jones, D., Newsom–Davis, J., et al. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1405.020 · Cited by 94
Major pathogenic effects of anti-MuSK antibodies in Myasthenia Gravis
Boneva, N., Frenkian, M., Bidault, J., Brenner, T., & Berrih‐Aknin, S. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.017 · Cited by 49
Self-citationDouble seronegative myasthenia gravis with anti-LRP 4 antibodies
Zouvelou, V., Zisimopoulou, P., Rentzos, M., Karandreas, N., Evangelakou, P., Stamboulis, E., & Tzartos, S. J. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.03.013 · Cited by 35
Self-citation
Cited by
Gilhus, N. E., Tzartos, S., Evoli, A., Palace, J., Burns, T. M., & Verschuuren, J. J. G. M. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0079-y · Cited by 953
Self-citationHoward, J. F., Bril, V., Vu, T., Karam, C., Peric, S., Margania, T., Murai, H., Bilinska, M., Shakarishvili, R., Smilowski, M., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00159-9 · Cited by 739
Self-citationMyasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations
Dresser, L., Wlodarski, R., Rezania, K., & Soliven, B. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112235 · Cited by 475
Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms
Berrih-Aknin, S., & Le Panse, R. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.011 · Cited by 383
Self-citationThe Regulation of Bone Metabolism and Disorders by Wnt Signaling
Maeda, K., Kobayashi, Y., Koide, M., Uehara, S., Okamoto, M., Ishihara, A., Kayama, T., Saito, M., & Marumo, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225525 · Cited by 353
Metadata
- Authors
- Zisimopoulou, P., Evangelakou, P., Tzartos, J., Lazaridis, K., Zouvelou, V., Mantegazza, R., Antozzi, C., Andreetta, F., Evoli, A., Deymeer, F., Saruhan-Direskeneli, G., Durmus, H., Brenner, T., Vaknin, A., Berrih-Aknin, S., Frenkian Cuvelier, M., Stojkovic, T., DeBaets, M., Losen, M., Martinez-Martinez, P., Kleopa, K. A., Zamba-Papanicolaou, E., Kyriakides, T., Kostera-Pruszczyk, A., Szczudlik, P., Szyluk, B., Lavrnic, D., Basta, I., Peric, S., Tallaksen, C., Maniaol, A., & Tzartos, S. J.
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 52
- Pages
- 139-145
- ISSN
- 0896-8411 (ISSN-L)
- OpenAlex
- W2108207836
- Cited by
- 329
- References
- 17
- FWCI
- 11.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.